Article
Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
medRxiv · 2022 · Goswami, S.; Raychaudhuri, D.; Singh, P.; Natarajan, S. M.; Chen, Y.; Poon, C.; Hennessey, M.; Zhang, J.; Anandhan, S.; Kerrigan, B. P.; Macaluso, M. D.; He, Z.; Jindal, S.; Lang, F. F.; Basu, S.; Sharma, P.
Key facts
| Title | Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade |
|---|---|
| First author | Goswami, S.; Raychaudhuri, D.; Singh, P.; Natarajan, S. M.; Chen, Y.; Poon, C.; Hennessey, M.; Zhang, J.; Anandhan, S.; Kerrigan, B. P.; Macaluso, M. D.; He, Z.; Jindal, S.; Lang, F. F.; Basu, S.; Sharma, P. |
| Journal | medRxiv |
| Published | Nov 29, 2022 |
| DOI | 10.1101/2022.11.28.518243 |
| Product codes mentioned | GIA, MVU, PFF, PFT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1